Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-face pilot study of topical timolol, tetrachlorodecaoxide and oxymetazoline for post comedo extraction facial erythema
TCTR20210604003Phase 4Recruiting
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of timolol, tetrachlorodecaoxide, oxymetazoline in facial erythema, sponsored by None. Started Dec 2020; status: recruiting.
02
Drugs
timololtetrachlorodecaoxideoxymetazoline
03
Conditions
facial erythema
Beyond the preview
Go deeper on TCTR20210604003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210604003.